Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11884943 Engineered

Patent 11884943 was granted and assigned to Singular genomics Systems, Inc. on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Singular genomics Systems, Inc.
Singular genomics Systems, Inc.
0
Date Filed
October 5, 2021
0
Date of Patent
January 30, 2024
0
Patent Applicant
Singular genomics Systems, Inc.
Singular genomics Systems, Inc.
0
Patent Application Number
17494668
0
Patent Citations
‌
US Patent 8852910 Modified polymerases for improved incorporation of nucleotide analogues
0
‌
US Patent 9085762 Compositions and methods using split polymerases
0
‌
US Patent 9447389 Modified polymerases for improved incorporation of nucleotide analogues
0
‌
US Patent 9765309 Modified polymerases for improved incorporation of nucleotide analogues
0
‌
US Patent 10017750 Modified polymerases for improved incorporation of nucleotide analogues
0
‌
US Patent 10041115 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
0
‌
US Patent 10421996 Modified polymerases for improved incorporation of nucleotide analogues
0
‌
US Patent 11034942 Modified pyrococcus polymerases and uses thereof
0
‌
US Patent 10738072 Nucleotide analogues
0
‌
US Patent 7057026 Labelled nucleotides
0
•••
Patent Citations Received
‌
US Patent 12110515 Modified
0
Patent Inventor Names
Souad Naji
0
Eli N. Glezer
0
Zachary Terranova
0
Abrehet Abdu
0
Youngjin Cho
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11884943
0
Patent Primary Examiner
‌
Suzanne M Noakes
0

Find more entities like US Patent 11884943 Engineered

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.